U.S., May 3 -- ClinicalTrials.gov registry received information related to the study (NCT06955741) titled 'A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 in Healthy Participants' on April 25.
Brief Summary: The purpose of this study is to assess drug levels, tolerability and absolute biological availability of single subcutaneous dose of BMS-986446 in healthy participants
Study Start Date: May 06
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: BMS-986446 IV
Specified dose on specified days was administered intravenously (IV).
DRUG: BMS-986446 SC
Specified dose on specified days was administered subcutaneously (SC).
DRUG: Acetaminophen
Spec...